Maintenance Therapy With Sunitinib or Observation in Metastatic Pancreatic Cancer
NCT00967603
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
56
Enrollment
OTHER
Sponsor class
Conditions
Pancreatic Cancer
Interventions
DRUG:
sunitinib
Sponsor
IRCCS San Raffaele